vs
Lantheus Holdings, Inc.（LNTH）与Rackspace Technology, Inc.（RXT）财务数据对比。点击上方公司名可切换其他公司
Rackspace Technology, Inc.的季度营收约是Lantheus Holdings, Inc.的1.7倍（$682.8M vs $406.8M），Lantheus Holdings, Inc.净利率更高（13.3% vs -4.8%，领先18.1%），Lantheus Holdings, Inc.同比增速更快（4.0% vs -0.4%），Lantheus Holdings, Inc.自由现金流更多（$81.4M vs $56.0M），过去两年Lantheus Holdings, Inc.的营收复合增速更高（4.9% vs -0.6%）
Lantheus Holdings是一家全球性医疗保健企业，专注于研发、生产及商业化创新诊断显像剂与相关解决方案，产品覆盖肿瘤学、心脏病学、泌尿学等核心医疗领域，主要市场遍及北美及全球其他重点地区。
Rackspace Technology, Inc.是总部位于美国得克萨斯州圣安东尼奥的云计算企业，在弗吉尼亚州雷斯顿以及澳大利亚、加拿大、英国、印度、迪拜、瑞士、荷兰、德国、新加坡、墨西哥、中国香港等多个国家和地区设有办事处，数据中心分布于全球多个主要城市，为客户提供专业的云计算相关服务。
LNTH vs RXT — 直观对比
营收规模更大
RXT
是对方的1.7倍
$406.8M
营收增速更快
LNTH
高出4.4%
-0.4%
净利率更高
LNTH
高出18.1%
-4.8%
自由现金流更多
LNTH
多$25.4M
$56.0M
两年增速更快
LNTH
近两年复合增速
-0.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $406.8M | $682.8M |
| 净利润 | $54.1M | $-32.7M |
| 毛利率 | 59.2% | 17.6% |
| 营业利润率 | 19.0% | -0.5% |
| 净利率 | 13.3% | -4.8% |
| 营收同比 | 4.0% | -0.4% |
| 净利润同比 | 558.8% | 41.6% |
| 每股收益（稀释后） | $0.86 | $-0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LNTHRXT
| Q4 25 | $406.8M | $682.8M | ||
| Q3 25 | $384.0M | $671.2M | ||
| Q2 25 | $378.0M | $666.3M | ||
| Q1 25 | $372.8M | $665.4M | ||
| Q4 24 | $391.1M | $685.6M | ||
| Q3 24 | $378.7M | $675.8M | ||
| Q2 24 | $394.1M | $684.9M | ||
| Q1 24 | $370.0M | $690.8M |
净利润LNTHRXT
| Q4 25 | $54.1M | $-32.7M | ||
| Q3 25 | $27.8M | $-67.1M | ||
| Q2 25 | $78.8M | $-54.5M | ||
| Q1 25 | $72.9M | $-71.5M | ||
| Q4 24 | $-11.8M | $-56.0M | ||
| Q3 24 | $131.1M | $-186.6M | ||
| Q2 24 | $62.1M | $25.0M | ||
| Q1 24 | $131.1M | $-640.6M |
毛利率LNTHRXT
| Q4 25 | 59.2% | 17.6% | ||
| Q3 25 | 57.9% | 19.4% | ||
| Q2 25 | 63.8% | 19.4% | ||
| Q1 25 | 63.8% | 19.1% | ||
| Q4 24 | 63.5% | 19.2% | ||
| Q3 24 | 63.9% | 20.3% | ||
| Q2 24 | 64.9% | 19.2% | ||
| Q1 24 | 65.4% | 19.2% |
营业利润率LNTHRXT
| Q4 25 | 19.0% | -0.5% | ||
| Q3 25 | 11.4% | -5.1% | ||
| Q2 25 | 23.3% | -3.8% | ||
| Q1 25 | 27.4% | -5.8% | ||
| Q4 24 | 29.1% | -4.2% | ||
| Q3 24 | 35.3% | -25.7% | ||
| Q2 24 | 26.1% | -7.9% | ||
| Q1 24 | 28.8% | -94.5% |
净利率LNTHRXT
| Q4 25 | 13.3% | -4.8% | ||
| Q3 25 | 7.2% | -10.0% | ||
| Q2 25 | 20.8% | -8.2% | ||
| Q1 25 | 19.6% | -10.7% | ||
| Q4 24 | -3.0% | -8.2% | ||
| Q3 24 | 34.6% | -27.6% | ||
| Q2 24 | 15.8% | 3.7% | ||
| Q1 24 | 35.4% | -92.7% |
每股收益（稀释后）LNTHRXT
| Q4 25 | $0.86 | $-0.13 | ||
| Q3 25 | $0.41 | $-0.28 | ||
| Q2 25 | $1.12 | $-0.23 | ||
| Q1 25 | $1.02 | $-0.31 | ||
| Q4 24 | $-0.18 | $-0.20 | ||
| Q3 24 | $1.79 | $-0.82 | ||
| Q2 24 | $0.88 | $0.11 | ||
| Q1 24 | $1.87 | $-2.91 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $359.1M | $105.8M |
| 总债务越低越好 | $568.7M | $2.7B |
| 股东权益账面价值 | $1.1B | $-1.2B |
| 总资产 | $2.2B | $2.8B |
| 负债/权益比越低杠杆越低 | 0.52× | — |
8季度趋势，按日历期对齐
现金及短期投资LNTHRXT
| Q4 25 | $359.1M | $105.8M | ||
| Q3 25 | $382.0M | $99.5M | ||
| Q2 25 | $695.6M | $103.9M | ||
| Q1 25 | $938.5M | $128.0M | ||
| Q4 24 | $912.8M | $144.0M | ||
| Q3 24 | $866.4M | $157.1M | ||
| Q2 24 | $757.0M | $190.2M | ||
| Q1 24 | $718.3M | $282.6M |
总债务LNTHRXT
| Q4 25 | $568.7M | $2.7B | ||
| Q3 25 | $567.9M | $2.8B | ||
| Q2 25 | $566.8M | $2.8B | ||
| Q1 25 | $566.1M | $2.8B | ||
| Q4 24 | $565.3M | $2.8B | ||
| Q3 24 | $613.0K | $2.8B | ||
| Q2 24 | $563.2M | $2.9B | ||
| Q1 24 | $562.5M | $3.0B |
股东权益LNTHRXT
| Q4 25 | $1.1B | $-1.2B | ||
| Q3 25 | $1.1B | $-1.2B | ||
| Q2 25 | $1.2B | $-1.1B | ||
| Q1 25 | $1.2B | $-1.1B | ||
| Q4 24 | $1.1B | $-1.0B | ||
| Q3 24 | $1.2B | $-949.7M | ||
| Q2 24 | $1.0B | $-756.2M | ||
| Q1 24 | $945.5M | $-787.2M |
总资产LNTHRXT
| Q4 25 | $2.2B | $2.8B | ||
| Q3 25 | $2.3B | $2.8B | ||
| Q2 25 | $2.1B | $2.9B | ||
| Q1 25 | $2.1B | $3.0B | ||
| Q4 24 | $2.0B | $3.1B | ||
| Q3 24 | $2.0B | $3.1B | ||
| Q2 24 | $1.9B | $3.4B | ||
| Q1 24 | $1.8B | $3.5B |
负债/权益比LNTHRXT
| Q4 25 | 0.52× | — | ||
| Q3 25 | 0.51× | — | ||
| Q2 25 | 0.49× | — | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 0.52× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.55× | — | ||
| Q1 24 | 0.59× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $90.2M | $59.7M |
| 自由现金流经营现金流 - 资本支出 | $81.4M | $56.0M |
| 自由现金流率自由现金流/营收 | 20.0% | 8.2% |
| 资本支出强度资本支出/营收 | 2.2% | 0.5% |
| 现金转化率经营现金流/净利润 | 1.67× | — |
| 过去12个月自由现金流最近4个季度 | $354.1M | $90.6M |
8季度趋势，按日历期对齐
经营现金流LNTHRXT
| Q4 25 | $90.2M | $59.7M | ||
| Q3 25 | $105.3M | $70.7M | ||
| Q2 25 | $87.1M | $8.4M | ||
| Q1 25 | $107.6M | $12.6M | ||
| Q4 24 | $157.7M | $54.3M | ||
| Q3 24 | $175.1M | $51.8M | ||
| Q2 24 | $84.7M | $24.1M | ||
| Q1 24 | $127.2M | $-90.3M |
自由现金流LNTHRXT
| Q4 25 | $81.4M | $56.0M | ||
| Q3 25 | $94.7M | $42.7M | ||
| Q2 25 | $79.1M | $-12.4M | ||
| Q1 25 | $98.8M | $4.3M | ||
| Q4 24 | $141.4M | $34.4M | ||
| Q3 24 | $159.3M | $27.3M | ||
| Q2 24 | $73.5M | $-14.5M | ||
| Q1 24 | $119.0M | $-118.4M |
自由现金流率LNTHRXT
| Q4 25 | 20.0% | 8.2% | ||
| Q3 25 | 24.7% | 6.4% | ||
| Q2 25 | 20.9% | -1.9% | ||
| Q1 25 | 26.5% | 0.6% | ||
| Q4 24 | 36.1% | 5.0% | ||
| Q3 24 | 42.0% | 4.0% | ||
| Q2 24 | 18.7% | -2.1% | ||
| Q1 24 | 32.2% | -17.1% |
资本支出强度LNTHRXT
| Q4 25 | 2.2% | 0.5% | ||
| Q3 25 | 2.8% | 4.2% | ||
| Q2 25 | 2.1% | 3.1% | ||
| Q1 25 | 2.3% | 1.2% | ||
| Q4 24 | 4.2% | 2.9% | ||
| Q3 24 | 4.2% | 3.6% | ||
| Q2 24 | 2.8% | 5.6% | ||
| Q1 24 | 2.2% | 4.1% |
现金转化率LNTHRXT
| Q4 25 | 1.67× | — | ||
| Q3 25 | 3.79× | — | ||
| Q2 25 | 1.11× | — | ||
| Q1 25 | 1.47× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.34× | — | ||
| Q2 24 | 1.36× | 0.96× | ||
| Q1 24 | 0.97× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LNTH
| Radiopharmaceutical Oncology | $240.2M | 59% |
| Definity | $85.3M | 21% |
| Strategic Partnerships And Other | $23.3M | 6% |
| Techne Lite | $21.0M | 5% |
| Licenseand Royalty Revenues | $17.4M | 4% |
| Other | $13.6M | 3% |
| Other Precision Diagnostics | $5.9M | 1% |
RXT
| Public Cloud Services Segment | $442.2M | 65% |
| Private Cloud Service Segment | $240.6M | 35% |
